본문바로가기
Wellmarker Bio, a predictive biomarker based anti-cancer drug development company has raised $18million in Series B funding round in 8th of July. 


LInk: https://www.edaily.co.kr/news/read?newsId=02322246622552552&mediaCodeNo=257&OutLnkChk=Y

List